China Resources Pharmaceutical Group (01093.HK): Ustekinumab Injection Approved by National Medical Products Administration for Marketing.

Wisdom Finance APP news, Sihuan Pharmaceutical Holdings Group (01093.HK) announced that the group's developed product Ulinastatin Injection (trade name: Enyike) has been approved for market by the China National Medical Products Administration.